Document detail
ID

doi:10.1007/s40620-023-01841-3...

Author
Adenwalla, S. F. O’Halloran, P. Faull, C. Murtagh, F. E. M. Graham-Brown, M. P. M.
Langue
en
Editor

Springer

Category

Urology

Year

2024

listing date

1/24/2024

Keywords
advance care planning dialysis end-stage kidney disease end of life palliative review current care advance planning
Metrics

Abstract

Patients with end-stage kidney disease (ESKD) have a high symptom-burden and high rates of morbidity and mortality.

Despite this, evidence has shown that this patient group does not have timely discussions to plan for deterioration and death, and at the end of life there are unmet palliative care needs.

Advance care planning is a process that can help patients share their personal values and preferences for their future care and prepare for declining health.

Earlier, more integrated and holistic advance care planning has the potential to improve access to care services, communication, and preparedness for future decision-making and changing circumstances.

However, there are many barriers to successful implementation of advance care planning in this population.

In this narrative review we discuss the current evidence for advance care planning in patients on dialysis, the data around the barriers to advance care planning implementation, and interventions that have been trialled.

The review explores whether the concepts and approaches to advance care planning in this population need to be updated to encompass current and future care.

It suggests that a shift from a problem-orientated approach to a goal-orientated approach may lead to better engagement, with more patient-centred and satisfying outcomes.

Graphical abstract

Adenwalla, S. F.,O’Halloran, P.,Faull, C.,Murtagh, F. E. M.,Graham-Brown, M. P. M., 2024, Advance care planning for patients with end-stage kidney disease on dialysis: narrative review of the current evidence, and future considerations, Springer

Document

Open

Share

Source

Articles recommended by ES/IODE AI

Bone metastasis prediction in non-small-cell lung cancer: primary CT-based radiomics signature and clinical feature
non-small-cell lung cancer bone metastasis radiomics risk factor predict cohort model cect cancer prediction 0 metastasis radiomics clinical